Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study
帕米帕利单药治疗既往接受过至少两线化疗的携带生殖系 BRCA1/2 突变的卵巢癌患者:一项多中心、开放标签的 II 期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-1186
Wu, Xiaohua; Zhu, Jianqing; Wang, Jing; Lin, Zhongqiu; Yin, Rutie; Sun, Wei; Zhou, Qi; Zhang, Songling; Wang, Danbo; Shi, Hong; Gao, Yunong; Huang, Yi; Li, Guiling; Wang, Xiuli; Cheng, Ying; Lou, Ge; Gao, Qinglei; Wang, Li; Du, Xiuping; Pan, Mei; Mu, Xiyan; Li, Li; Li, Miao; Mu, Song; Kong, Beihua